Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Study of Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

KEY contacts

Rory Collins (University of Oxford)

Jane Armitage (University of Oxford)

Data ownership

Clinical Trial Service Unit and Epidemiological Unit (CTSU), University of Oxford


Merck; CTSU also received funding from the UK Medical Research Council and the British Heart Foundation.




Other trial-related materials